Agensys' Acquisition

Agensys was acquired by Astellas Pharma on December 10, 2007.

Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validat…

Articles about Agensys' Acquisition: